ArticleJournal of medicinal chemistry2025

Discovery of a "First-in-Class" Selective Multikinase (CDK4/6/9-AURKA/B) Inhibitor, LCI133, for Neuroblastoma.

Krishnaiah Maddeboina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.